RxDoctor Payments Data

Secil Aydinoz, MD

Pediatrics · Columbia, MONPI 1306407853

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 54.3% of the total. Among pediatrics clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,915in general payments, 2019–2025

Across 86 payments — averaging $57.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$3K
  • Jazz Pharmaceuticals Inc.$628
  • Avadel CNS Pharmaceuticals, LLC$460
  • Harmony Biosciences LLC$443
  • Axsome Therapeutics, Inc.$328
  • Sanofi$125
  • plus $260 from 10 others

What the payments were for

  • Consulting fees$3507%
  • Travel & lodging$2,03341%
  • Food & beverage$2,33247%
  • Education$2004%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,915 in reported general payments places this provider in the 95th percentile of 1,306 pediatrics providers in Missouri.

See all pediatrics providers in Missouri

Medicare billing

Part B allowed, 2024
$58,830
Medicare patients
266
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate27$502,482
ProvigilModafinil16$47,001
SunosiSolriamfetol Hcl19$20,897
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine191$8,812
Armodafinil69$6,442
Modafinil79$5,731
DayvigoLemborexant11$4,240
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine70$4,063
Dextroamphetamine Sulfate43$3,533
Lisdexamfetamine Dimesylate15$2,624
Methylphenidate Hcl46$2,091
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate24$1,858
Zolpidem Tartrate108$688
Ropinirole Hcl36$598
Carbidopa-LevodopaCarbidopa/Levodopa17$507

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Axsome Therapeutics, Inc.Sunosi$328$20,89719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,306 pediatrics providers in Missouri.

Other pediatrics in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →